Apellis to Present Data on APL-2 in Complement 3 Glomerulopathy at ASN Kidney Week 2019

NEXT STORY
Retrophin Announces Presentation of Abstracts at ASN Kidney Week 2019
PREV STORY
Roxadustat Global Phase 3 Results for Treatment of Chronic Kidney Disease (CKD) Anemia to be Presented at American Society of Nephrology Kidney Week 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast’s Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome

author_avatar
NASDAQ Market News

XBiotech Announces On-Time Submission to the EMA

AUSTIN, Texas, March 27, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that ...

author_avatar
NASDAQ Market News

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2021

author_avatar
NASDAQ Market News